Assessing the severity of atrophic gastritis

Atrophic gastritis, mainly the consequence of long-standing Helicobacter pylori infection, is linked to the development of gastric cancer. In the case of atrophic gastritis, severity may be mainly related to the lifetime risk of the single patient to develop gastric cancer, mostly in relation to the degree and extension of mucosal damage. As atrophic gastritis is the result of complex multifactorial interactions, the application of artificial neural networks is promising and may be useful for the identification of those patients with atrophic gastritis at higher risk for gastric malignancies. The experience of application of artificial neural networks in atrophic gastritis is still scarce. The available data suggest that these systems may contribute to identify patients with corporal metaplastic atrophic gastritis and to optimize bioptic sampling during gastroscopy.

[1]  Y. Yamaoka,et al.  Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. , 1996, Gastroenterology.

[2]  M. Rugge,et al.  Staging and grading of chronic gastritis. , 2005, Human pathology.

[3]  L. Franzén,et al.  Prevalence of Subtypes of Intestinal Metaplasia in the General Population and in Patients with Autoimmune Chronic Atrophic Gastritis , 2002, Scandinavian journal of gastroenterology.

[4]  C. Prinz,et al.  Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. , 2003, The Journal of infectious diseases.

[5]  M. Carrington,et al.  Interleukin-1 polymorphisms associated with increased risk of gastric cancer , 2000, Nature.

[6]  Amitabh Chak,et al.  Prediction of outcome in acute lower-gastrointestinal haemorrhage based on an artificial neural network: internal and external validation of a predictive model , 2003, The Lancet.

[7]  A. Oshima,et al.  Fundal atrophic gastritis as a risk factor for gastric cancer , 1993, International journal of cancer.

[8]  R. Negrini,et al.  Two‐thirds of Atrophic Body Gastritis Patients Have Evidence of Helicobacter pylori Infection , 2001, Helicobacter.

[9]  M. Rasmussen,et al.  Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study , 2003, European journal of gastroenterology & hepatology.

[10]  G. Capurso,et al.  The stomach and iron deficiency anaemia: a forgotten link. , 2003, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[11]  N. Sasaki,et al.  Helicobacter pylori infection and the development of gastric cancer. , 2001, The New England journal of medicine.

[12]  E. Kuipers.  In through the out door: serology for atrophic gastritis , 2003, European journal of gastroenterology & hepatology.

[13]  S. V. van Deventer,et al.  Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. , 1994, Scandinavian journal of gastroenterology.

[14]  J. Smith,et al.  Is subtyping of intestinal metaplasia in the upper gastrointestinal tract a worthwhile exercise? An evaluation of current mucin histochemical stains , 2003, British journal of biomedical science.

[15]  L. Murray,et al.  Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori. , 2000, Gastroenterology.

[16]  S. Passi,et al.  Concomitant alterations in intragastric pH and ascorbic acid concentration in patients with Helicobacter pylori gastritis and associated iron deficiency anaemia , 2003, Gut.

[17]  Chien-Jen Chen,et al.  Host-Environment Interactions: Their Impact on Progression from Gastric Inflammation to Carcinogenesis and on Development of New Approaches to Prevent and Treat Gastric Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[18]  P. Malfertheiner,et al.  Formation of nitrite in gastric juice of patients with various gastric disorders after ingestion of a standard dose of nitrate--a possible risk factor in gastric carcinogenesis. , 1984, IARC scientific publications.

[19]  Paulo J. G. Lisboa,et al.  A review of evidence of health benefit from artificial neural networks in medical intervention , 2002, Neural Networks.

[20]  M. Rugge,et al.  Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading , 2002, Alimentary pharmacology & therapeutics.

[21]  M. Haber.  Histologic precursors of gastrointestinal tract malignancy. , 2003, Gastroenterology clinics of North America.

[22]  S. Angeletti,et al.  High prevalence of atrophic body gastritis in patients with unexplained microcytic and macrocytic anemia: A prospective screening study , 1999 .

[23]  Noam Harpaz,et al.  Artificial neural networks distinguish among subtypes of neoplastic colorectal lesions. , 2002, Gastroenterology.

[24]  G. Capurso,et al.  Gastrointestinal causes of refractory iron deficiency anemia in patients without gastrointestinal symptoms. , 2001, The American journal of medicine.

[25]  M. Baker,et al.  Pernicious anemia. , 1947, American practitioner and digest of treatment.

[26]  D. Beall.  Classification and Grading of Gastritis: The Updated Sydney System , 1997 .

[27]  N. Muñoz,et al.  Intestinal metaplasia types and the risk of gastric cancer: A cohort study in Slovenia , 1994, International journal of cancer.

[28]  I. Beales,et al.  Interleukin 1β and tumour necrosis factor α inhibit acid secretion in cultured rabbit parietal cells by multiple pathways , 1998 .

[29]  D. Graham,et al.  Changes in the gastric mucosa following eradication of Helicobacter pylori. , 1993, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[30]  C. Pusey,et al.  Long-term sequelae of Helicobacter pylori gastritis , 1995, The Lancet.

[31]  E. El-Omar,et al.  Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. , 2002, Gastroenterology.

[32]  B. Sheu,et al.  Computerized Diagnosis of Helicobacter pylori Infection and Associated Gastric Inflammation from Endoscopic Images by Refined Feature Selection Using a Neural Network , 2004, Endoscopy.

[33]  Massimo Buscema,et al.  Possible contribution of artificial neural networks and linear discriminant analysis in recognition of patients with suspected atrophic body gastritis. , 2005, World journal of gastroenterology.

[34]  D. Graham,et al.  Topographic patterns of intestinal metaplasia and gastric cancer. , 2000 .

[35]  M. Cattaruzza,et al.  Long‐term follow‐up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection , 2005, Alimentary pharmacology & therapeutics.

[36]  H. Adami,et al.  The risk of stomach cancer in patients with gastric or duodenal ulcer disease. , 1996, The New England journal of medicine.

[37]  M F Dixon,et al.  Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. , 1996, The American journal of surgical pathology.

[38]  P. Correa,et al.  Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. , 1992, Cancer research.